The company expects adverse foreign currency effects on sales to be about $25 million and on operating income to be about $20 million with most of the impact in the third quarter. The company offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA, an oral therapy for the treatment of chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy, with or without ribavirin, for adults with genotype 1 chronic hepatitis, counting those with compensated cirrhosis. Renaissance Technologies LLC raised its stake in Abercrombie & Fitch Co.by 370.5% in the first quarter. Acadian Asset Management LLC now owns 2,209,548 shares of the apparel retailer’s stock worth $69,689,000 after buying an additional 820,959 shares in the last quarter. The price-earnings ratio (P/E Ratio) is the ratio for valuing a company that measures its current share price relative to its per-share earnings. 18 analysts have suggested the company is a “Hold”. 19 analysts said “Hold” signal for the stock. Investors should trade with caution and watch out for further signals. Abercrombie & Fitch Co. now has a consensus rating of Hold and an average price target of $24.60. It has 67.65 million of outstanding shares and its shares float measured at 67.14. After the session opened at $109.25, the stock’s price hit the top of $ 109.37 while it touched a low of $ 108.91. Volume of trade was was up over the average, with 16,756,100 shares of ANF changing hands over the typical 2,539,690 shares. The previous close of the stock was called at $108.95.
Advertisement
The company has encountered a twelve month cheapest price of $ 87.30 and hit a twelve month expensive price of $ 111.83. It expects the back half of the year to be just as bad – if not worse than – what it just went through. The stock has earnings growth of 35.70% yoy and showed a low EPS growth of -21.60% over the past five years.
A number of other equities analysts have also commented on the stock. Research analysts have a consensus long-term estimate of $15.6 on the company. Deutsche Bank AG restated a hold rating and issued a $20.00 price target (down from $23.00) on shares of Abercrombie & Fitch Co.in a research report on Monday, August 15th. Using this scale, a 1 represents a Strong Buy while a 5 represents a Strong Sell. Recently, analysts have updated the mean rating to 2.3.
United Parcel Service, Inc.’s (UPS) price volatility for a month noted as 0.77% however its price volatility for a week documented as 0.72%.
“There’s a massive effort going on to figure out how to position Hollister and Abercrombie, but whether it can be done remains to be seen”, Cohen told Retail Dive.
Advertisement
Abercrombie & Fitch was once the premier teen retailer, but today is one that has been unable to successfully reposition itself to address changing consumer tastes and trends.
